| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, Lorglumide, CCK1 (CCKA) Antagonists targeting CCKAR (Novartis, 3960) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/3960 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the CA-26-BI29_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| MRPL37 | mitochondrial ribosomal protein L37 | 1.18725 |
| DDTL | D-dopachrome tautomerase-like | 0.454652 |
| CCT7 | chaperonin containing TCP1, subunit 7 (eta) | 0.277034 |
| RPL5 | ribosomal protein L5 | 0.216711 |
| Symbol | Name | Standardized Value |
|---|---|---|
| MED10 | mediator complex subunit 10 | -0.209726 |